We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Duckhorn Portfolio Inc | NYSE:NAPA | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.02 | 0.18% | 11.00 | 11.02 | 10.98 | 10.99 | 1,505,348 | 22:00:00 |
☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☒
|
Definitive Proxy Statement
|
☐
|
Definitive Additional Materials
|
☐
|
Soliciting Material Pursuant to §240.14a-12
|
The Duckhorn Portfolio, Inc.
|
(Name of Registrant as Specified In Its Charter)
|
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
| |
Sincerely,
|
|
| |
|
|
| |
|
|
| |
Alex Ryan
|
|
| |
President, Chief Executive Officer and Chairman of the Board of Directors
|
1.
|
Election of the three director nominees named in the Proxy Statement to serve until the annual meeting of stockholders
occurring in the fiscal year ending July 31, 2025 (“Fiscal 2025”);
|
2.
|
Ratification of the appointment of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accounting firm for
the fiscal year ending July 31, 2022 (“Fiscal 2022”);
|
3.
|
Approval, on an advisory basis, of the compensation of our named executive officers;
|
4.
|
Approval, on an advisory basis, of the frequency of future stockholder advisory votes on the compensation of our named
executive officers; and
|
5.
|
Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
|
| |
By Order of the Board of Directors,
|
|
| |
|
|
| |
|
|
| |
Sean Sullivan
|
|
| |
Executive Vice President,
Chief Administrative Officer and
General Counsel
|
1.
|
Election of the three director nominees named in the Proxy Statement to serve until the Fiscal 2025 annual meeting of
stockholders;
|
2.
|
Ratification of the appointment of PwC as our independent registered public accounting firm for Fiscal 2022;
|
3.
|
Approval, on an advisory basis, of the compensation of the Company’s named executive officers;
|
4.
|
Approval, on an advisory basis, of the frequency of future stockholder advisory votes on the compensation of our named
executive officers; and
|
5.
|
Transacting such other business as may properly come before the meeting or any adjournment thereof.
|
•
|
Election of the three director nominees named in this Proxy Statement to serve until the Fiscal 2025 annual meeting of
stockholders;
|
•
|
Ratification of the appointment of PwC as our independent registered public accounting firm for Fiscal 2022;
|
•
|
Approval, on an advisory basis, of the compensation of our named executive officers; and
|
•
|
Approval, on an advisory basis, of the frequency of future stockholder advisory votes on the compensation of our named
executive officers.
|
•
|
During the meeting - You may attend
the Annual Meeting virtually or in person and cast your vote then. If you have already voted online, by telephone or by mail, your vote at the Annual Meeting will supersede your prior vote.
|
•
|
By proxy - Stockholders of record have a choice of voting by proxy or during the
virtual meeting:
|
○
|
over the Internet at www.virtualshareholdermeeting.com/NAPA2022;
|
○
|
by using a toll-free telephone number noted on your proxy card; or
|
○
|
by executing and returning a proxy card and mailing it in the postage-paid envelope provided.
Please allow sufficient time for delivery of your proxy card if you decide to vote by mail.
|
•
|
“FOR” the election of the Board’s nominees;
|
•
|
“FOR” the ratification of the appointment of PwC;
|
•
|
“FOR” the advisory approval of the compensation of our named executive officers; and
|
•
|
To hold future advisory votes on the compensation of our named executive officers every “THREE
YEARS”.
|
•
|
Entering a new vote online;
|
•
|
Entering a new vote by telephone;
|
•
|
Signing and returning a new proxy card bearing a later date, which will automatically revoke your earlier proxy instructions;
or
|
•
|
Attending the Annual Meeting virtually or in person and voting during the meeting.
|
Name
|
| |
Age
|
| |
Position
|
Alex Ryan
|
| |
55
|
| |
President, Chief Executive Officer and Chairman
|
Daniel Costello
|
| |
40
|
| |
Director
|
Melanie Cox
|
| |
61
|
| |
Director
|
Charles Esserman
|
| |
63
|
| |
Director
|
Michelle Gloeckler
|
| |
55
|
| |
Director
|
Deirdre Mahlan
|
| |
59
|
| |
Director
|
James O’Hara
|
| |
55
|
| |
Director
|
✓
|
| |
Accountability. Our Common Stock outstanding on the Record Date is entitled to
one vote per matter presented to stockholders
|
| |
✓
|
| |
Annual Named Executive Officer Performance Evaluation by the Compensation
Committee of the Board
|
|
| |
|
| |
|
| |
|
✓
|
| |
Clawback and Anti-Hedging Policies for Directors, Executive Officers and other
Employees
|
| |
✓
|
| |
Limitation on Management Directors. Our CEO is the only member of management who
serves as a director
|
|
| |
|
| |
|
| |
|
✓
|
| |
Regular Board and Committee Executive Sessions of Non-Management Directors
|
| |
✓
|
| |
Audit Committee Approval Required for Related Party Transactions
|
|
| |
|
| |
|
| |
|
✓
|
| |
“Pay for Performance” Philosophy Drives Executive Compensation
|
| |
✓
|
| |
No “Poison Pill” (Stockholder Rights Plan)
|
|
| |
|
| |
|
| |
|
✓
|
| |
Independent Executive Compensation Consultant
|
| |
✓
|
| |
Commitment to Diversity, Equity and Inclusion
|
|
| |
|
| |
|
| |
|
✓
|
| |
Risk Oversight by the Board and its Committees
|
| |
✓
|
| |
Established Whistleblower Policy
|
|
| |
|
| |
|
| |
|
✓
|
| |
Annual Board and Committee Self-Evaluations
|
| |
✓
|
| |
Commitment to Environmental, Social and Governance Leadership
|
•
|
Class I, which consists of Alex Ryan, Daniel Costello and Deirdre Mahlan, whose terms will expire at our Fiscal 2022 annual
meeting of stockholders;
|
•
|
Class II, which consists of Melanie Cox and James O’Hara, whose terms will expire at our Fiscal 2023 annual meeting of
stockholders; and
|
•
|
Class III, which consists of Charles Esserman and Michelle Gloeckler, whose terms will expire at our Fiscal 2024 annual meeting
of stockholders.
|
•
|
for so long as TSG owns at least 50% of the shares of our common stock held by TSG immediately prior to the completion of the
IPO, TSG will be entitled to designate four individuals for nomination;
|
•
|
for so long as TSG owns less than 50% but at least 25% of the shares of our common stock held by TSG immediately prior to the
completion of the IPO, TSG will be entitled to designate three individuals for nomination;
|
•
|
for so long as TSG owns less than 25% but at least 10% of the shares of our common stock held by TSG immediately prior to the
completion of the IPO, TSG will be entitled to designate two individuals for nomination; and
|
•
|
for so long as TSG owns less than 10% but at least 5% of the shares of our common stock held by TSG immediately prior to the
completion of the IPO, TSG will be entitled to designate one individual for nomination.
|
•
|
appointing, approving the compensation of, and assessing the qualifications, performance and independence of our independent
registered public accounting firm;
|
•
|
pre-approving audit and permissible non-audit services, and the terms of such services, to be provided by our independent
registered public accounting firm;
|
•
|
reviewing the audit plan with the independent registered public accounting firm and members of management responsible for
preparing our financial statements;
|
•
|
reviewing and discussing with management and the independent registered public accounting firm our annual and quarterly
financial statements and related disclosures as well as critical accounting policies and practices used by us;
|
•
|
reviewing the adequacy of our internal control over financial reporting;
|
•
|
reviewing all related person transactions for potential conflict of interest situations and approving all such transactions;
|
•
|
establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns;
|
•
|
recommending, based upon the Audit Committee’s review and discussions with management and the independent registered public
accounting firm, the inclusion of our audited financial statements in our Annual Report on Form 10-K;
|
•
|
reviewing and assessing the adequacy of the committee charter and submitting any changes to the Board for approval;
|
•
|
monitoring our compliance with legal and regulatory requirements as they relate to our financial statements and accounting
matters;
|
•
|
preparing the Audit Committee report required by the rules of the SEC to be included in our annual proxy statement; and
|
•
|
reviewing and discussing with management and our independent registered public accounting firm our earnings releases.
|
•
|
determining and approving the compensation of our chief executive officer, including annually reviewing and approving corporate
goals and objectives relevant to the compensation of our chief executive officer, and evaluating the performance of our chief executive officer in light of such corporate goals and objectives;
|
•
|
reviewing and approving the corporate goals and objectives relevant to the compensation of our other executive officers;
|
•
|
reviewing and approving the compensation of our other executive officers;
|
•
|
appointing, compensating and overseeing the work of any compensation consultant, legal counsel or other advisor retained by the
Compensation Committee;
|
•
|
conducting the independence assessment outlined in the rules of the NYSE with respect to any compensation consultant, legal
counsel or other advisor retained by the Compensation Committee;
|
•
|
reviewing and assessing the adequacy of the committee charter and submitting any changes to the Board for approval;
|
•
|
reviewing and establishing our overall management compensation philosophy and policy;
|
•
|
overseeing and administering our equity compensation and similar plans;
|
•
|
reviewing and approving our policies and procedures for the grant of equity-based awards and granting equity awards;
|
•
|
reviewing and making recommendations to the Board with respect to director compensation; and
|
•
|
reviewing and discussing with management the compensation discussion and analysis to be included in our annual proxy statement
or Annual Report on Form 10-K.
|
•
|
developing and recommending to the Board criteria for board and committee membership;
|
•
|
establishing procedures for identifying and evaluating board of director candidates, including nominees recommended by
stockholders;
|
•
|
identifying individuals qualified to become members of the Board;
|
•
|
recommending to the Board the persons to be nominated for election as directors and to each of the Board’s committees;
|
•
|
overseeing the Company’s environmental, social and governance (“ESG”) initiatives;
|
•
|
developing and recommending to the Board a set of corporate governance principles;
|
•
|
articulating to each director what is expected, including reference to the corporate governance principles and directors’
duties and responsibilities;
|
•
|
reviewing and recommending to the Board practices and policies with respect to directors;
|
•
|
reviewing and recommending to the Board the functions, duties and compositions of the committees of the Board;
|
•
|
reviewing and assessing the adequacy of the committee charter and submitting any changes to the Board for approval;
|
•
|
provide for new director orientation and continuing education for existing directors on a periodic basis;
|
•
|
performing an evaluation of the performance of the committee; and
|
•
|
overseeing the evaluation of the Board and management.
|
|
| |
Fiscal year ended July 31,
|
|||
|
| |
2021
|
| |
2020
|
Audit fees(a)
|
| |
$2,827,500
|
| |
$496,000
|
Audit-related fees(b)
|
| |
90,802
|
| |
49,131
|
Tax fees
|
| |
—
|
| |
—
|
All other fees
|
| |
—
|
| |
—
|
Total fees
|
| |
$2,918,302
|
| |
$545,131
|
(a)
|
Audit fees were for professional services rendered for the audit of our consolidated financial statements, reviews of the
interim consolidated financial statements included in quarterly reports, the review of our Registration Statement on Form S-1 for our initial public offering and services that are normally provided by PwC in connection with the financial
statement audit.
|
(b)
|
Audit-related fees were for assurance and related services that are reasonably related to the performance of the audit or review
of our consolidated financial statements and are not reported under “Audit fees.”
|
•
|
Alex Ryan, our President, Chief Executive Officer and Chairman;
|
•
|
Lori Beaudoin, our Executive Vice President, Chief Financial Officer; and
|
•
|
Pete Przybylinski, our Executive Vice President, Chief Sales Officer.
|
Name and principal position
|
| |
Year
|
| |
Salary
($)(1)
|
| |
Bonus
($)(2)
|
| |
Stock
awards
($)(3)
|
| |
Option
awards
($)(4)
|
| |
Nonequity incentive
plan compensation
($)(5)
|
| |
All other
compensation
($)(6)
|
| |
Total
($)
|
Alex Ryan
|
| |
2021
|
| |
564,910
|
| |
—
|
| |
2,031,480
|
| |
1,652,673
|
| |
764,720
|
| |
81,778
|
| |
5,095,561
|
President, Chief Executive Officer and Chairman
|
| |
2020
|
| |
530,450
|
| |
252,871
|
| |
—
|
| |
—
|
| |
—
|
| |
53,045
|
| |
836,366
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Lori Beaudoin
|
| |
2021
|
| |
365,150
|
| |
—
|
| |
1,015,728
|
| |
826,325
|
| |
425,000
|
| |
53,689
|
| |
2,685,892
|
Executive Vice President, Chief Financial Officer
|
| |
2020
|
| |
339,900
|
| |
140,039
|
| |
—
|
| |
—
|
| |
—
|
| |
37,590
|
| |
517,529
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Pete Przybylinski
|
| |
2021
|
| |
355,156
|
| |
—
|
| |
777,729
|
| |
632,710
|
| |
356,956
|
| |
49,390
|
| |
2,171,941
|
Executive Vice President, Chief Sales Officer(7)
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
(1)
|
The amounts reported for each named executive officer include contributions made by the executive to the Company’s 401(k) plan,
described below.
|
(2)
|
The amounts reported in this column represent the annual bonuses paid to Mr. Ryan and Ms. Beaudoin with respect to Fiscal 2020.
|
(3)
|
The amounts reported in this column represent the grant date value of restricted stock units (“RSUs”) granted to our named
executive officers in Fiscal 2021, computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures. The assumptions used to value the RSUs for this purpose are set forth in Note 15 (Equity-based compensation)
to our consolidated financial statements included elsewhere in this Annual Report.
|
(4)
|
The amounts reported in this column represent the grant date value of options to purchase shares of our common stock granted to
our named executive officers in Fiscal 2021, computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures. The assumptions used to value the options for this purpose are set forth in Note 15 (Equity-based
compensation) to our consolidated financial statements included elsewhere in this Annual Report.
|
(5)
|
The amounts reported in this column represent the annual bonuses paid to our named executive officers with respect to Fiscal 2021.
|
(6)
|
The amounts reported in this column for Fiscal 2021 represent Company contributions to the Company’s 401(k) plan of $29,000 for
each of our named executive officers and Company contributions to our nonqualified deferred compensation plan of $52,778 for Mr. Ryan, $21,089 for Ms. Beaudoin and $20,390 for Mr. Przybylinski. These plans are described in more detail
under “Employee benefits” below. The amount reported in this column for Fiscal 2021 for Ms. Beaudoin also includes a $300 monthly payment ($3,600 in the aggregate) in lieu of Company-provided health and welfare benefits.
|
(7)
|
No amounts are reported in this table for Mr. Przybylinski for Fiscal 2020 because Mr. Przybylinski was not a named executive
officer for that year.
|
Named executive officer
|
| |
Grant date
|
| |
Number of shares of
common stock subject
to option
|
| |
Number of RSUs
|
Alex Ryan
|
| |
March 17, 2021
|
| |
278,833
|
| |
92,944
|
|
| |
June 18, 2021
|
| |
79,665
|
| |
26,555
|
Lori Beaudoin
|
| |
March 17, 2021
|
| |
139,416
|
| |
46,472
|
|
| |
June 18, 2021
|
| |
39,831
|
| |
13,277
|
Pete Przybylinski
|
| |
March 17, 2021
|
| |
106,750
|
| |
35,583
|
|
| |
June 18, 2021
|
| |
30,498
|
| |
10,166
|
|
| |
Option awards
|
| |
Stock awards
|
||||||||||||
Name
|
| |
Number of
securities underlying
unexercised
options
exercisable
(#)
|
| |
Number of
securities underlying
unexercised
options
unexercisable
(#)
|
| |
Option
exercise
price
($/share)
|
| |
Option
expiration
date
|
| |
Number of
shares of stock
that have not
vested (#)
|
| |
Market value
of shares of
stock that have
not vested ($)(1)
|
Alex Ryan
|
| |
—
|
| |
278,833
|
| |
15.00
|
| |
3/17/2031(2)
|
| |
—
|
| |
—
|
|
| |
—
|
| |
79,665
|
| |
24.00
|
| |
6/18/2031(3)
|
| |
—
|
| |
—
|
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
92,944(4)
|
| |
2,041,980
|
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
131,472(5)
|
| |
2,888,440
|
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
26,555(6)
|
| |
583,413
|
Lori Beaudoin
|
| |
—
|
| |
139,416
|
| |
15.00
|
| |
3/17/2031(2)
|
| |
—
|
| |
—
|
|
| |
—
|
| |
39,831
|
| |
24.00
|
| |
6/18/2031(3)
|
| |
—
|
| |
—
|
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
46,472(4)
|
| |
1,020,990
|
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
68,003(5)
|
| |
1,494,026
|
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
13,277(6)
|
| |
291,696
|
Pete Przybylinski
|
| |
—
|
| |
106,750
|
| |
15.00
|
| |
3/17/2031(2)
|
| |
—
|
| |
—
|
|
| |
—
|
| |
30,498
|
| |
24.00
|
| |
6/18/2031(3)
|
| |
—
|
| |
—
|
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
35,583(4)
|
| |
781,759
|
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
45,335(5)
|
| |
996,010
|
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
| |
10,166(6)
|
| |
223,347
|
(1)
|
Based on the closing price of a share of our common stock ($21.97) on July 30, 2021, the last trading day of Fiscal 2021.
|
(2)
|
Represents options granted on March 17, 2021 that vest in four equal installments on each of the first four anniversaries of the
vesting commencement date (which was March 17, 2021), generally subject to the named executive officer’s continued service through the applicable vesting date.
|
(3)
|
Represents options granted on June 18, 2021 that vest in four equal installments on each of the first four anniversaries of the
vesting commencement date (which was March 17, 2021), generally subject to the named executive officer’s continued service through the applicable vesting date.
|
(4)
|
Represents RSUs granted on March 17, 2021 that vest in four equal installments on each of the first four anniversaries of the
vesting commencement date (which was March 17, 2021), generally subject to the named executive officer’s continued service through the applicable vesting date.
|
(5)
|
Represents shares of restricted stock received in exchange for unvested Class M Common Units of Mallard Holdco, LLC held by the
named executive officer in connection with our initial public offering that remained unvested as of July 31, 2021, which vested as to 1/3 of the shares on August 1, 2021 and vest as to the remaining 2/3 of the shares on August 1, 2022,
generally subject to the named executive officer’s continued service through such date.
|
(6)
|
Represents RSUs granted on June 18, 2021 that vest in four equal installments on each of the first four anniversaries of the
vesting commencement date (which was March 17, 2021), generally subject to the named executive officer’s continued service through the applicable vesting date.
|
Name
|
| |
Fees earned or
paid in cash
($)(1)
|
| |
Stock awards
($)(2)
|
| |
Total
($)
|
Daniel Costello(3)
|
| |
—
|
| |
—
|
| |
—
|
Melanie Cox(4)
|
| |
29,916
|
| |
105,000
|
| |
134,916
|
Dan Duckhorn(5)
|
| |
93,750
|
| |
249,990
|
| |
343,740
|
Charles Esserman(3)
|
| |
—
|
| |
—
|
| |
—
|
Michelle Gloeckler(6)
|
| |
15,218
|
| |
72,483
|
| |
87,701
|
Deirdre Mahlan(7)
|
| |
32,907
|
| |
105,000
|
| |
137,907
|
James O'Hara(3)
|
| |
—
|
| |
—
|
| |
—
|
(1)
|
The amount reported in this column represents cash fees earned in Fiscal 2021.
|
(2)
|
The amounts reported in this column represent the grant date value of RSUs granted to our non-employee directors in Fiscal 2021,
computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures. The assumptions used to value the RSUs for this purpose are set forth in Note 15 (Equity-based compensation) to our consolidated financial
statements included elsewhere in this Annual Report. As of July 31, 2021, the following current and former non-employee directors held unvested RSUs in the following amounts:
|
Non-employee director
|
| |
Number of unvested RSUs
|
Melanie Cox
|
| |
7,000
|
Dan Duckhorn
|
| |
16,666
|
Michelle Gloeckler
|
| |
4,417
|
Deirdre Mahlan
|
| |
7,000
|
(3)
|
Messrs. Esserman, O’Hara and Costello are affiliated with TSG. Members of our Board who are affiliated with our investors do not
receive compensation in respect of their service on our board. See “Certain relationships and related transactions.”
|
(4)
|
Ms. Cox joined the Board in March 2021.
|
(5)
|
Mr. Duckhorn retired from the Board on February 19, 2021 and remains an advisor to the Company.
|
(6)
|
Ms. Gloeckler joined the Board in May 2021.
|
(7)
|
Ms. Mahlan joined the Board in March 2021.
|
|
| |
Member
|
| |
Lead director
or committee chair
|
Annual cash retainer for Board members
|
| |
$60,000
|
| |
$75,000
|
Additional annual cash retainer for compensation committee
|
| |
$8,500
|
| |
$15,000
|
Additional annual cash retainer for nominating and corporate
governance committee
|
| |
$5,000
|
| |
$10,000
|
Additional annual cash retainer for audit committee
|
| |
$10,000
|
| |
$20,000
|
•
|
Provide base salaries that are consistent with similar positions in similar companies;
|
•
|
Directly connect incentive pay to company performance and achievement of corporate goals;
|
•
|
Align the interests of our named executive officers with those of our stockholders;
|
•
|
Provide benefits to our named executive officers that are generally the same as those provided to our other employees; and
|
•
|
Attract, motivate and retain talented executives in a competitive environment.
|
Name
|
| |
Age
|
| |
Position
|
Alex Ryan(1)
|
| |
55
|
| |
President, Chief Executive Officer and Chairman
|
Lori Beaudoin
|
| |
61
|
| |
Executive Vice President, Chief Financial Officer
|
Sean Sullivan
|
| |
41
|
| |
Executive Vice President, Chief Administrative Officer and General Counsel
|
Pete Przybylinski
|
| |
54
|
| |
Executive Vice President, Chief Sales Officer
|
Zach Rasmuson
|
| |
48
|
| |
Executive Vice President, Chief Operating Officer
|
Carol Reber
|
| |
53
|
| |
Executive Vice President, Chief Marketing and DTC Officer
|
(1)
|
See “Board of Directors” for a description of Alex Ryan’s experience.
|
|
| |
Common Stock
beneficially owned11
|
|||
Name of beneficial owner
|
| |
Number
|
| |
Percentage
|
5% stockholders:
|
| |
|
| |
|
Mallard Holdco, LLC(1)
|
| |
74,150,301
|
| |
64.5%
|
|
| |
|
| |
|
Directors and named executive officers:
|
| |
|
| |
|
Alex Ryan(2)
|
| |
1,666,123
|
| |
1.4%
|
Lori Beaudoin(3)
|
| |
849,595
|
| |
*
|
Daniel Costello(4)
|
| |
—
|
| |
*
|
Melanie Cox(5)
|
| |
7,000
|
| |
*
|
Charles Esserman(4)
|
| |
—
|
| |
*
|
Michelle Gloeckler(5)
|
| |
4,417
|
| |
*
|
Deirdre Mahlan(5)
|
| |
7,000
|
| |
*
|
James O’Hara(4)
|
| |
—
|
| |
*
|
Pete Przybylinski(6)
|
| |
509,897
|
| |
*
|
Zach Rasmuson(7)
|
| |
522,009
|
| |
*
|
Carol Reber(8)
|
| |
531,592
|
| |
*
|
Sean Sullivan(9)
|
| |
162,514
|
| |
*
|
All executive officers and directors as a group (12 persons)
|
| |
4,260,147
|
| |
3.7%
|
(*)
|
Represents beneficial ownership or voting power of less than 1%.
|
(1)
|
Consists of 74,150,301 shares of common stock, held directly by Mallard Holdco, LLC. Voting and investment decisions with
respect to securities held by Mallard Holdco, LLC are made by a committee of three or more individuals, none of whom individually has the power to direct such decisions. The address of Mallard Holdco, LLC is c/o TSG Consumer Partners,
LLC, 600 Montgomery Street, Suite 2900, San Francisco, CA 94111.
|
(2)
|
Includes 87,648 shares of restricted stock subject to a time-based vesting condition that vest on August 1, 2022, held by the
Alex and Jeanine Ryan 2015 Revocable Trust, for which Mr. Ryan is trustee.
|
(3)
|
Includes 45,335 shares of restricted stock subject to a time-based vesting condition that vest on August 1, 2022, held by the
Brian and Lori Beaudoin Trust 2005, as amended and restated in 2012, for which Ms. Beaudoin is trustee.
|
(4)
|
Does not include shares of common stock beneficially owned by Mallard Holdco, LLC. Mr. Esserman is Chief Executive Officer of
TSG, Mr. O’Hara is President of TSG and Mr. Costello is Managing Director of TSG, and therefore may be deemed to beneficially own such shares, however each disclaims beneficial ownership of such shares.
|
(5)
|
These shares are subject to a time-based vesting condition that vests at the Annual Meeting of Stockholders on January 18, 2022.
|
(6)
|
Includes 30,224 shares of restricted stock subject to a time-based vesting condition that vest on August 1, 2022, held by The
Przybylinski Family Trust dated July 24, 2006, for which Mr. Przybylinski is trustee.
|
(7)
|
Includes 30,224 shares of restricted stock subject to a time-based vesting condition that vest on August 1, 2022, held by
Mr. Rasmuson.
|
(8)
|
Includes 30,224 shares of restricted stock subject to a time-based vesting condition that vest on August 1, 2022, held by The
Robert and Carol Reber Revocable Living Trust, for which Ms. Reber is trustee.
|
(9)
|
Includes 42,503 shares of restricted stock subject to a time-based vesting condition that vest on August 1, 2022, held by
Mr. Sullivan.
|
|
| |
Respectfully submitted,
|
|
| |
|
|
| |
THE AUDIT COMMITTEE
|
|
| |
|
|
| |
Daniel Costello
|
|
| |
Michelle Gloeckler
|
|
| |
Deirdre Mahlan
|
1 Year Duckhorn Portfolio Chart |
1 Month Duckhorn Portfolio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions